Purchase Order 75N91023P00738

Award Date 8/30/23
Potential Completion Date 8/29/24
Potential Value $69K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $315,770.00 firm-fixed-price purchase order to Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis, doing business as Stichting NKI-AVL, a non-profit cancer research institute and clinic in the Netherlands. The purpose of the contract is to collect, harmonize, and manage pathology treatment and survival data that is being contributed to the Confluence Project from...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm-fixed-price purchase order to Deutsches Krebsforschungszentrum (DKFZ), a non-profit organization and foundation, to provide services for the collection, harmonization, and management of breast cancer risk factor data being contributed to the Confluence Project from the Breast Cancer Association Consortium (BCAC). The base period of performance for this contract is from September...
This firm-fixed price purchase order for $241,990 was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to The Trustees of Columbia University in the City of New York. The contract supports large-scale data analysis to characterize variations in cancer treatments across the United States to assist the NCI's Division of Cancer Control and Population Sciences. The prime contractor, Columbia University, is...
The Department of Health and Human Services' National Institutes of Health's National Cancer Institute awarded a firm fixed price task order worth $15,281 under an unspecified government-wide acquisition contract vehicle to the Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency. The task order calls for linking clinical practice data from the Clinical Practice Research Datalink to the National Cancer Data Registry database to study reproductive risk...
This firm fixed price contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the United Kingdom's Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency. The $185,877.28 contract provides the NCI's Division of Cancer Epidemiology and Genetics (DCEG) with a one-year license to access the Clinical Practice Research Datalink (CPRD) medical records database, which contains...
This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to the United Kingdom's Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency. The contract provides the NCI with access to the Clinical Practice Research Datalink (CPRD) database and linkages to the National Cancer Data Registry, to support the NCI's epidemiological cancer research. Specific studies will...
This firm fixed price Blanket Purchase Agreement (BPA) call award from the Department of Health and Human Services' National Institutes of Health's National Cancer Institute provides the prime contractor, the United Kingdom's Department of Health known as the Medicines & Healthcare Products Regulatory Agency, with a license to access the Clinical Practice Research Datalink (CPRD) National Cancer Data Registry (NCDR) database. Valued at one hundred seventy-three thousand one hundred...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $16,265 purchase order to Capralogics Inc. for testing services. The firm fixed price contract will be performed in Hardwick, Massachusetts over a three-month period from July 1, 2023 through September 30, 2023. As the intramural research program of the NCI, a component of the NIH focused on cancer research, this contract supports the agency's mission to lead the nation's...
The National Cancer Institute, a component of the Department of Health and Human Services, awarded a $489,805 firm fixed price purchase order to Biofortis, LLC. The contract provides for Biofortis Labmatrix clinical and translational research management software subscriptions, maintenance, and development support services over a base period of performance from August 2021 through August 2022. The original solicitation sought these capabilities on a sole source basis from Biofortis to provide...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $3,547.70 firm fixed price delivery order contract to Olgoonik Federal LLC. The contract, numbered NCI-23-099, will be performed in Bethesda, Maryland from July 24, 2023 through October 24, 2023. The National Cancer Institute is the federal agency responsible for cancer research within the United States. While details of the products or services requested were not provided, this delivery...

This firm fixed-price purchase order, valued at $68,640, was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health within the Department of Health and Human Services, to Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis, doing business as Stichting NKI-AVL. Under this contract, the contractor will collect, harmonize, and manage clinical trial data being contributed to the Confluence Project from European clinical trials. The Confluence Project aims to facilitate sharing of cancer research data. Work will be performed in Bethesda, Maryland over a one year period ending in August 2024. No set aside designation or involvement of major subcontractors was noted. This award furthers NCI's mission to catalyze the generation and application of cancer research data through international collaboration.

Generated 12/15/23, 8:26 PM